Literature DB >> 1700774

Rod electroretinograms in an elevated cyclic guanosine monophosphate-type human retinal degeneration. Comparison with retinitis pigmentosa.

M A Sandberg1, S Miller, E L Berson.   

Abstract

Unusual rod electroretinogram (ERG) intensity-response functions were recorded from three female patients with retinal degeneration who had visual acuities of 20/200, retinal arteriolar narrowing, and diffuse granularity of the retinal pigment epithelium. All three patients had rod b-waves that were profoundly subnormal in amplitude and markedly delayed in implicit time to bright stimuli. Rod a-wave slopes were reduced 50% below normal, indicating photoreceptor involvement. These unusual rod ERG intensity-response functions are similar to those previously reported for the isolated cat eye with elevated retinal cyclic guanosine monophosphate (cGMP) after perfusion with isobutylmethylxanthine. This finding supports the idea that these three patients may have an elevation of retinal cGMP. Their rod ERG intensity-response functions are contrasted with those recorded from some patients with retinitis pigmentosa.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700774

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  A detailed phenotypic study of "cone dystrophy with supernormal rod ERG".

Authors:  M Michaelides; G E Holder; A R Webster; D M Hunt; A C Bird; F W Fitzke; J D Mollon; A T Moore
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

2.  ISCEV extended protocol for the stimulus-response series for the dark-adapted full-field ERG b-wave.

Authors:  Mary A Johnson; Brett G Jeffrey; André M V Messias; Anthony G Robson
Journal:  Doc Ophthalmol       Date:  2019-03-30       Impact factor: 2.379

3.  Experiences with the international standard for clinical electroretinography: normative values for clinical practice, interindividual and intraindividual variations and possible extensions.

Authors:  P C Jacobi; K D Miliczek; E Zrenner
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

4.  Evidence supportive of a functional discrimination between photopic oscillatory potentials as revealed with cone and rod mediated retinopathies.

Authors:  P Lachapelle; S Rousseau; M McKerral; J Benoit; R C Polomeno; R K Koenekoop; J M Little
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

5.  Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause "cone dystrophy with supernormal rod electroretinogram" in humans.

Authors:  Huimin Wu; Jill A Cowing; Michel Michaelides; Susan E Wilkie; Glen Jeffery; Sharon A Jenkins; Viktoria Mester; Alan C Bird; Anthony G Robson; Graham E Holder; Anthony T Moore; David M Hunt; Andrew R Webster
Journal:  Am J Hum Genet       Date:  2006-07-24       Impact factor: 11.025

6.  Cone dysfunction and supernormal scotopic electroretinogram with a high-intensity stimulus. A report of three cases.

Authors:  M Kato; R Kobayashi; I Watanabe
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

7.  Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa.

Authors:  M E McLaughlin; T L Ehrhart; E L Berson; T P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

8.  PIII and derived PII analysis in a patient with retinal dysfunction with supernormal scotopic ERG.

Authors:  Naoyuki Tanimoto; Tomoaki Usui; Mikio Ichibe; Mineo Takagi; Shigeru Hasegawa; Haruki Abe
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 1.854

Review 9.  The role of voltage-gated ion channels in visual function and disease in mammalian photoreceptors.

Authors:  Rabab Rashwan; David M Hunt; Livia S Carvalho
Journal:  Pflugers Arch       Date:  2021-07-13       Impact factor: 3.657

10.  Rod and cone function in patients with KCNV2 retinopathy.

Authors:  Ditta Zobor; Susanne Kohl; Bernd Wissinger; Eberhart Zrenner; Herbert Jägle
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.